2/5
08:46 am
ptct
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 [Yahoo! Finance]
Low
Report
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 [Yahoo! Finance]
2/5
08:00 am
ptct
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026
Low
Report
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026
1/29
10:59 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "hold" rating reaffirmed by analysts at TD Cowen.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "hold" rating reaffirmed by analysts at TD Cowen.
1/27
06:00 pm
ptct
PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
1/12
08:51 am
ptct
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference [Yahoo! Finance]
Low
Report
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference [Yahoo! Finance]
1/12
08:30 am
ptct
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference
Low
Report
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference
1/8
04:30 pm
ptct
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/8
08:02 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
1/3
01:08 am
ptct
PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at
Wall Street Z
Low
Report
PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at
Wall Street Z
12/30
04:14 pm
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
12/23
02:16 am
ptct
Japan Sephience Approval Could Be A Game Changer For PTC Therapeutics' (PTCT) Rare-Disease Strategy [Yahoo! Finance]
Low
Report
Japan Sephience Approval Could Be A Game Changer For PTC Therapeutics' (PTCT) Rare-Disease Strategy [Yahoo! Finance]
12/23
01:35 am
ptct
PTC Therapeutics (PTCT): Valuation Check After First Japan Approval Completes Global Sephience Launch [Yahoo! Finance]
Low
Report
PTC Therapeutics (PTCT): Valuation Check After First Japan Approval Completes Global Sephience Launch [Yahoo! Finance]
12/22
07:15 am
ptct
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan [Yahoo! Finance]
Low
Report
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan [Yahoo! Finance]
12/22
07:00 am
ptct
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan
Low
Report
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan
12/22
01:46 am
ptct
?????(TM)(???????)??????????(PKU)??????????????? [CNET News]
Low
Report
?????(TM)(???????)??????????(PKU)??????????????? [CNET News]
12/19
04:30 pm
ptct
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/18
08:39 am
ptct
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/18
08:00 am
ptct
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/2
04:26 pm
ptct
Principal Spectrum Preferred Secs Active ETF declares monthly distribution of $0.0827 [Seeking Alpha]
Medium
Report
Principal Spectrum Preferred Secs Active ETF declares monthly distribution of $0.0827 [Seeking Alpha]
12/2
04:26 pm
ptct
Principal Investment Grade Corporate Active ETF declares monthly distribution of $0.0792 [Seeking Alpha]
Medium
Report
Principal Investment Grade Corporate Active ETF declares monthly distribution of $0.0792 [Seeking Alpha]
12/1
06:19 pm
ptct
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
12/1
04:30 pm
ptct
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/1
06:04 am
ptct
PTC Therapeutics (NASDAQ:PTCT) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating.
Medium
Report
PTC Therapeutics (NASDAQ:PTCT) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating.
11/29
07:23 pm
ptct
How The Sephience Launch Is Reshaping The Story For PTC Therapeutics's Valuation [Yahoo! Finance]
Medium
Report
How The Sephience Launch Is Reshaping The Story For PTC Therapeutics's Valuation [Yahoo! Finance]
11/29
11:56 am
ptct
A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000 [Yahoo! Finance]
Medium
Report
A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000 [Yahoo! Finance]